肿瘤细胞治疗研究
ALL SOURCES
A conceptual exploration on the synergistic anti-tumor effects of high-order combination of OHSV2-DSTE(FAP5/CD3), CAR-T cells, and immunotoxins in hep
这种高阶联合代表了一种针对肝细胞癌的新型多波次免疫治疗策略。
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D.
尽管CAR-T（CAR-T）细胞在血液系统恶性肿瘤中取得了显著成功，但 CAR-T 细胞对实体瘤的疗效仍不理想。
Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors.
这些结果表明，GPC3 特异性 7sFv-T 细胞可能成为实体瘤的一种有前景的治疗策略。
A novel PD-L1-targeted shark V(NAR) single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer.
本研究为在临床研究中使用PD-L1 CAR-T细胞作为单一疗法或与肿瘤特异性疗法联合使用提供了理论依据。
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
